https://www.marketscreener.com/quote/stock/ARIX-BIOSCIENCE-PLC-34067690/news/Arix-Bioscience-VelosBio-Announces-First-Patient-Dosed-in-Phase-2-Trial-of-VLS-101-in-Solid-Tumors-31567721/?utm_source=telegram&utm_medium=social&utm_campaign=share